Institutional changes and their impacts on the Brazilian Pharmaceutical Industry: Is there an Innovation System on the way?

dc.contributor.author Urias, Eduardo
dc.contributor.author Furtado, João
dc.contributor.corporatename Universidade Estadual de Campinas
dc.contributor.corporatename Escola Politécnica de São Paulo
dc.date.accessioned 2010-12-13T20:56:46Z
dc.date.available 2010-12-13T20:56:46Z
dc.date.issued 2009-10-08
dc.description Parallel session 6. Innovation systems in bio-technology and pharmaceuticals
dc.description Presented at GLOBELICS 2009, 7th International Conference, 6-8 October, Dakar, Senegal. en_US
dc.description.abstract The Brazilian legislation did not recognize pharmaceutical patents for products and processes up until 1996, an exemption which started in 1945 for products and 1969, for processes. In this period, the domestic companies freely reproduced medicines developed by large companies from abroad and commercialized them in the local market with their own trademarks. They applied considerable efforts and resources in marketing, aiming to consolidate their brands next to the medical class, but they did not had to face the costs of research and development (R&D). This strategy guaranteed a considerable profitability for the domestic laboratories, but it was made impracticable by the new institutional landmark that emerged after the regulation of the Patents Law (“Lei de Propriedade Intelectual” – number 9.279 of 05/14/1996) and the Generic Medicines Law (“Lei do Medicamento Genérico” – number 9.787 of 02/10/1999). This article illustrates, through analysis based on information obtained from secondary sources, interviews and a Panel of Specialists, how the new competitive environment forced the companies to adopt a new strategic position, in which innovation gained importance. en_US
dc.identifier.uri http://hdl.handle.net/1853/36348
dc.language.iso en_US en_US
dc.publisher Georgia Institute of Technology en_US
dc.relation.ispartofseries GLOBELICS09. Session 6 en_US
dc.subject Sectoral systems of innovation en_US
dc.subject Institutional change en_US
dc.subject Research, development and innovation en_US
dc.subject Brazilian pharmaceutical firms en_US
dc.title Institutional changes and their impacts on the Brazilian Pharmaceutical Industry: Is there an Innovation System on the way? en_US
dc.type Text
dc.type.genre Proceedings
dspace.entity.type Publication
local.contributor.corporatename School of Public Policy
local.contributor.corporatename Ivan Allen College of Liberal Arts
local.relation.ispartofseries Globelics Conference
relation.isOrgUnitOfPublication a3789037-aec2-41bb-9888-1a95104b7f8c
relation.isOrgUnitOfPublication b1049ff1-5166-442c-9e14-ad804b064e38
relation.isSeriesOfPublication 9bcdf48e-4586-4550-b033-2063df2fe342
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
411.98 KB
Adobe Portable Document Format